L2 Asset Management, LLC Eli Lilly & CO Transaction History

L2 Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $26,714 - $31,374	86 Added 4.46%	2,014 $691,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $109,648 - $127,762	341 Added 21.49%	1,928 $705,000
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $58,110 - $66,222	196 Added 14.09%	1,587 $513,000
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $6,968 - $8,181	25 Added 1.83%	1,391 $451,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $51,631 - $64,165	220 Added 19.2%	1,366 $391,000
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $257,678 - $319,779	1,146 New	1,146 $317,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $772,000 - $929,094	-5,659 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $36,667 - $45,383	308 Added 5.76%	5,659 $785,000
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $572,128 - $708,632	5,351 New	5,351 $703,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on L2 Asset Management, LLC with notifications on news.